Skip to main content
SpringerLink
Log in

Naloxone potentiates the release of oxytocin induced by systemic administration of cholecystokinin without enhancing the electrical activity of supraoptic oxytocin neurones

  • Regular Papers
  • Published:
Experimental Brain Research Aims and scope Submit manuscript

Summary

Studies performed in conscious female rats confirmed that iv injection of cholecystokinin octapeptide (CCK; 20µ/kg) increased the circulating concentration of oxytocin but not that of vasopressin, and confirmed that the stimulation of oxytocin release was markedly facilitated after iv administration of naloxone (1mg/kg), indicating attenuation of oxytocin release by endogenous opioids. To investigate the site of action of the endogenous opioids, the electrical activity of putative oxytocin neurones in the supraoptic nucleus was recorded in urethaneanaesthetised female rats. Oxytocin neurones responded to CCK injection with an increase in firing rate lasting 5–15 min, but this response was not facilitated by prior injection of naloxone. The results suggest that the opioid influence upon CCK-induced oxytocin release operates at the level of the neurosecretory terminals in the neurohypophysis rather than centrally. Since CCK does not elevate vasopressin release, it appears unlikely that dynorphin, the opioid peptide co-existing with vasopressin, is responsible in these circumstances for the cross-inhibition of oxytocin release. It is suggested that products of proenkephalin A, the met-enkephalin precursor present in the supraoptic nucleus and in the neurohypophysis itself, may be active in the regulation of oxytocin release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bicknell RJ, Leng G (1982) Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis. Nature 298:161–162

    Article  PubMed  Google Scholar 

  • Bicknell RJ, Brown D, Chapman C, Hancock PD, Leng G (1984) Reversible fatigue of stimulus-secretion coupling in the rat neurophypophysis. J Physiol (Lond) 348:601–613

    PubMed  Google Scholar 

  • Blackburn RE, Leng G (1990) Abalation of the region anterior and ventral to the third ventricle (AV3V region) in the rat does not abolish the release of oxytocin in response to systemic cholecystokinin. Brain Res 508:156–160

    Article  PubMed  Google Scholar 

  • Bondy AB, Gainer H, Russell JT (1988) Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminal of the neural lobe. Endocrinology 122:1321–1327

    PubMed  Google Scholar 

  • Bondy CA, Jensen RT, Brady LS, Gainer H (1989) Cholecystokinin evokes secretion of oxytocin and vasopressin from rat neural lobe independent of external calcium. Proc Natl Acad Sci USA 886:5198–5201

    Google Scholar 

  • Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C (1985) Interaction of opiates with opioid binding sites in the bovine adrenal medulla. II Interaction with k sites. J Neurochem 45:688–699

    PubMed  Google Scholar 

  • Clarke G, Wood P, Merrick L, Lincoln DW (1979) Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones. Nature 282:746–748

    Article  PubMed  Google Scholar 

  • Clarke G, Wright DM (1984) A comparison of analgesia and suppression of oxytocin release by opiates. Br J Pharmacol 83:799–806

    PubMed  Google Scholar 

  • Coombes J, Russell JA (1988) Inhibition by a Kappa-opioid receptor agonist (U50 488H) of electrically-stimulated oxytocin secretion from the neurohypophysis and anaesthetised lactating rats. J Physiol (Lond) 410:34P

    Google Scholar 

  • Cutting R, Fitzsimons N, Gosden RS, Humphrey EM, Russell JA, Scott S, Stirland JA (1986) Evidence that morphine interrupts parturition in rats by inhibiting oxytocin secretion. J Physiol (Lond) 371:182P

    Google Scholar 

  • Dyball REJ, Koizmui K (1969) Electrical activity in the supraoptic and paraventricular nuclei associated with neurohypophysial hormone release. J Physiol (Lond) 201:711–722

    PubMed  Google Scholar 

  • Dyer RG, Weick RC, Mansfield S, Corbett H (1981) Secretion of luteinising hormone in ovariectomised adult rats treated neonatally with monosodium glutamate. J Endocrinol 91:341–346

    PubMed  Google Scholar 

  • Flanagan LM, Verbalis JG, Stricker EM (1988) Naloxone potentiation of effects of cholecystokinin and lithium chloride on oxytocin secretion, gastric motility and feeding. Neuroendocrinology 48:668–673

    PubMed  Google Scholar 

  • Gerstberger R, Baden N (1986) Dynorphin 1–8 binds to opiate kappa receptors in the neurohypophysis. Neuroendocrinology 42:376–382

    PubMed  Google Scholar 

  • Hatton GI (1990) Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog Neurobiol 34:437–504

    Article  PubMed  Google Scholar 

  • Herkenham M, Rice KC, Jacobson AE, Rothman RB (1986) Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa. Brain Res 382:365–371

    Article  PubMed  Google Scholar 

  • Higuchi T, Honda K, Fukuoka T, Negoro H, Wakabayashi K (1985) Release of oxytocin during suckling and parturition in the rat. J Endocrinol 105:339–346

    PubMed  Google Scholar 

  • Leng G (1980) Rat supraoptic neurones: the effects of locally applied hypertonic saline. J Physiol (Lond) 304:405–414

    PubMed  Google Scholar 

  • Leng G, Russell JA (1989) Opioids, oxytocin and parturition. In: Dyer RG and Bicknell RJ (ed) Brain Opioid Systems in Reproduction. Oxford University Press, pp 231–256

  • Leng G, Mansfield S, Bicknell RJ, Blackburn RE, Brown D, Chapman C, Dyer RG, Hollingsworth S, Shibuki K, Yates JO, Way S (1988) Endogenous opioid actions and effects of environmental disturbance on parturition and oxytocin secretion in rats. J Reprod Fertil 84:345–356

    PubMed  Google Scholar 

  • Leng G, Pumford K, Russell JA (1990) Actions of the K-type opioid receptor agonist U50 488H on oxytocin neurones in the supraoptic nucleus (SON) in normal and morphine-tolerant urethane anaesthetised rates. J Physiol (Lond) 420:71P

    Google Scholar 

  • Leng G, Way SA, Dyball REJ (1991) Identification of oxytocin cells in the rat supraoptic nucleus by their response to CCK injection. Neurosci Lett 122:159–162

    Article  PubMed  Google Scholar 

  • Lightman SL, Young W Scott III (1987) Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat. J Physiol (Lond) 394:23–29

    PubMed  Google Scholar 

  • Lorenz RG, Evans CJ, Barchas JD (1985) Effect of dehydration on prodynophin derived peptides in the neurointermediate lobe of the rat pituitary. Life Sci 37:1523–1528

    Article  PubMed  Google Scholar 

  • Martin R, Voigt KH (1981) Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis. Nature 289:502–504

    Article  PubMed  Google Scholar 

  • Martin R, Geis R, Holl R, Schafer M, Voigt KH (1983) Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophysis: immunoreactive methionine-enkephalin-, leucine-enkephalin- and cholecystokinin-like substances. Neuroscience 8:213–227

    Article  PubMed  Google Scholar 

  • Moore G, Lutterodt A, Burford G, Lederis K (1977) A highly specific antiserum for arginine vasopressin. Endocrinology 101:1421–1435

    PubMed  Google Scholar 

  • Schafer MK-H, Day R, Ortega MR, Akil H, Watson SJ (1990) Proenkephalin messenger RNA is expressed both in the rat anterior and posterior pituitary. Neuroendocrinology 51:444–448

    PubMed  Google Scholar 

  • Shibuki K, Leng G, Way SA (1988) Effects of naloxone and of intraperitoneal hypertonic saline upon oxytocin release and upon supraoptic neuronal activity. Neurosci Lett 88:75–80

    Article  PubMed  Google Scholar 

  • Summy-Long JY (1989) Cross-inhibition of oxytocin neurones during activation of the vasopressin system. In: Dyer RG, Bicknell RJ (eds) Brain opioid systems in reproduction. Oxford University Press, Oxford, pp 271–287

    Google Scholar 

  • Summy-Long JL, Miller DS, Rosella-Dampan LM, Hartman RD, Emmert SE (1984) A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin. Brain Res 309:362–366

    Article  PubMed  Google Scholar 

  • Watson SJ, Akil A, Fischli W, Goldstein A, Zimmermann E, Nilaver G, Wimersma Greidanus TB van (1982) Dynorphin and vasopressin; common localization in magnocellular neurones. Science 216:85–87

    PubMed  Google Scholar 

  • Whitnall MH, Gainer H, Cox BM, Molineaux CJ (1983) Dynorphin-A-(1–8) is contained within vasopressin neurosecretory vesicles in rat pituitary. Science 222:1137–1138

    PubMed  Google Scholar 

  • Zhao B-G, Chapman C, Bicknell RJ (1988a) Opioid-noradrenergic interactions in the neurohypophysis. Neuroendocrinology 48:16–24

    PubMed  Google Scholar 

  • Zhao B-G, Chapman C, Bicknell RJ (1988b) Functional K-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis. Brain Res 462:62–66

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AFRC Institute of Animal Physiology and Genetics Research, Babraham, CB2 4AT, Cambridge, UK

    G. Leng & S. A. Way

  2. Department of Anatomy, University of Cambridge, Downing Street, Cambridge, UK

    R. E. J. Dyball

Authors
  1. G. Leng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. E. J. Dyball
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. A. Way
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leng, G., Dyball, R.E.J. & Way, S.A. Naloxone potentiates the release of oxytocin induced by systemic administration of cholecystokinin without enhancing the electrical activity of supraoptic oxytocin neurones. Exp Brain Res 88, 321–325 (1992). https://doi.org/10.1007/BF02259107

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02259107

Key words

Search

Navigation